CENTOCOR REOPRO CAPTURE STUDY DATA RELEASE HELPS STOCK "MARCH" UP 7 POINTS
Executive Summary
Centocor, bolstered by the announcement of the preliminary results of the CAPTURE trial of ReoPro for adjunctive use in PTCA, marched upward 7 points to a new 1996 high of 36-1/8 at the end of March. The gain was the largest recorded for the F-D-C Index of 77 O-T-C stocks in March